Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signature of distribution agreement

5 Jun 2020 07:00

RNS Number : 0422P
Applied Graphene Materials PLC
05 June 2020
 

05 June 2020

Applied Graphene Materials plc

("Applied Graphene Materials", "AGM", "the Group" or "the Company")

 

Applied Graphene Materials signs distribution agreement with Dichem Polymers SA, Greece.

Agreement provides AGM with a strong route into the Greek coatings and polymers markets.

Applied Graphene Materials (LSE:AGM), is pleased to announce it has signed an exclusive distribution agreement with Dichem Polymers SA (Headquarters Acharnes, Greece). The agreement helps to extend AGM's commercial reach directly into the coatings and polymers sectors across Greece.

Founded in 1977, Dichem Group, has a strong history of delivering high performance chemicals to a wide range of markets including cosmetics, pharmaceuticals, food industry, polymers and coatings. The company's focus on supporting customers, with their specialist, technical focus, allows them the opportunity to actively participate in R&D programmes to establish new technologies in their selected sector.

AGM and Dichem have an exclusive agreement that will see the two companies collaborate on customer opportunities and introduce AGM's proprietary Genable® graphene dispersions technology into the Greek coatings and polymers market.

In addition to its own commercial hubs in the U.K. and the United States, AGM now has distribution agreements with local expert chemicals and coatings distributors in Greece, Italy, South Africa and Japan.

Adrian Potts, AGM CEO commented: 

"I am delighted to be able to continue the development of our platform for revenue generation with the addition of Dichem Polymers SA to the commercial team. Having done the hard work of developing graphene dispersions as the primary route to utilisation of nanoplatelet technology, we are pleased to be able to offer our standardised product offering to the global market through a strong distribution network across a growing number of countries. We are keen to advance our development pipeline for revenue through this approach from the sale of both our easy-to-use Genable® dispersions as well as customised product offerings to suit individual customer project requirements."

Demetrios Gkikas. Dichem Polymers CEO commented:

We are very pleased to have started a collaboration with AGM, a highly innovative organisation, with a technology that we expect to have significant growth in the Coatings Industry in the coming years. We believe that our long-standing relationships with local customers on one hand, and the high level of expertise of AGM on the other, will provide a clear benefit for those seeking a high-quality solution in certain sections of the Paint Industry. From our side we will do all we can to ensure this collaboration is very successful.

About Dichem Polymers SA

Dichem Polymers is active in the stocking and distribution of chemical raw materials for the construction, paint, insulation, packaging and signage industry. The company has been operating for 20 years in the Greek market where it also represents some of the largest international brands, constantly broadening its product, customer and supplier portfolio. Dichem Polymers' highly trained and skilled technical staff provide technical support at all levels (research, development and production of the final product).

http://www.dichem.gr/index.php?lang=EN

 

 

For further information, please contact:

 

Applied Graphene Materials

+44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

Notes to Editors

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications. The Group's strategy is to target commercial applications in three core markets: coatings, composites and functional materials.

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind this process.

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising £11 million, and is based at the Wilton Site on Teesside. In January 2016 the Group raised £8.5m to support its ongoing activities and in October 2017 the Group raised a further £9.8m.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKKQBQKBKBKAK
Date   Source Headline
25th Apr 20187:00 amRNSIssue of share options to Directors
18th Apr 20188:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSInterim Results
8th Mar 20187:00 amRNSCollaboration with SHD and Magna Exteriors
1st Feb 20187:00 amRNSBoard Change
15th Jan 20189:22 amRNSHolding(s) in Company
10th Jan 20185:30 pmRNSHolding(s) in Company
10th Jan 20184:40 pmRNSSecond Price Monitoring Extn
10th Jan 20184:35 pmRNSPrice Monitoring Extension
8th Jan 20181:21 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSResult of AGM
3rd Jan 20187:00 amRNSAGM Statement
12th Dec 20177:00 amRNSNotice of AGM
7th Nov 20179:47 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding
30th Oct 20171:15 pmRNSResults of Open Offer and General Meeting
12th Oct 20175:19 pmRNSPosting of Circular and Notice of General Meeting
10th Oct 20176:16 pmRNSFurther Details on the Fundraising
10th Oct 201711:41 amRNSClose of Accelerated Bookbuild
10th Oct 201711:00 amRNSPrice Monitoring Extension
10th Oct 20177:05 amRNSProposed Placing by Accelerated Bookbuild
10th Oct 20177:00 amRNSPreliminary Results
22nd Aug 20177:00 amRNSInvestor Site Visit
24th May 20177:00 amRNSNew Graphene Delivery Technology & Trading Update
22nd May 20174:18 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSInterim Results
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20174:40 pmRNSSecond Price Monitoring Extn
5th Apr 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSGrant of Options
30th Jan 20177:00 amRNSShare Purchase by CFO-Designate
25th Jan 20177:00 amRNSBoard & Operational Appointments
20th Dec 20167:00 amRNSAGM Statement
31st Oct 20167:01 amRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSFinal Results
14th Oct 20167:00 amRNSFirst Production Order
12th Aug 20167:38 amRNSExercise of Share Options and PDMR Dealing
12th Aug 20167:00 amRNSDirectorate Change
12th Aug 20167:00 amRNSPeriod end trading update and notice of results
8th Aug 20167:00 amRNSProduct Development and New JDA
23rd Mar 20167:00 amRNSInterim Results
26th Jan 20163:21 pmRNSHolding(s) in Company
26th Jan 201612:15 pmRNSResult of AGM
25th Jan 20167:00 amRNSAGM Statement
22nd Jan 201610:33 amRNSHolding(s) in Company
13th Jan 20169:08 amRNSHolding(s) in Company
11th Jan 20163:42 pmRNSIssue of share options to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.